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SIGAPS  is  a bibliometric  software  tool  developed  in  France  to  identify  and  analyze  Medline-indexed





the  author’s  ranking  on  the  paper  along  with  the  journal’s  prestige  according  to its  impact  factor  within
the  research  ﬁeld.  However,  use  of this  impact  factor  is the primary  limitation  of  SIGAPS. SIGAPS  analysis
results  are  used  to assign  a ﬁnancial  value  to hospital  facilities.  The  impact  of  the  journal  Revue  de Chirurgie
Orthopédique  and  its  successor–Orthopaedics  &  Traumatology:  Surgery  &  Research–was  compared  using
the  Medline-based  ISI  (SIGAPS)  and  SCOPUS-based  SCImago  journal  rankings.
© 2014  Elsevier  Masson  SAS.  All  rights  reserved.unding
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For a long time, the research activity at French University
ospital Centers (CHU) has been funded at a ﬁxed rate, typi-
ally 10.5% to 13% of the CHU’s budget. In 2007, this system
as replaced by MERRI funding (Missions d’enseignement, de
echerche, de référence, et d’innovation) (French teaching, research
nd innovation mandate). Research-oriented university hospitals,
on-university hospitals with signiﬁcant research activity and the
0 cancer research centers–more than 150 facilities in all–are eligi-
le for this funding. This model comprises a ﬁxed part, a ﬂexible part
nd a variable part. The ﬂexible part is determined using four indi-
ators: scientiﬁc publications, clinical trials, students and patents.
he patents indicator was eliminated in the 2013 MERRI.
To calculate the “publications” indicator, the French Ministry
f Health chose to use the bibliometric tool SIGAPS (Système
’interrogation, de gestionet d’analyse des publications scientiﬁques)
software to identify, manage and analyze scientiﬁc publications)
hat was developed by the Lille CHU in 2002 [1–3]. The prin-
iple behind this tool is that bibliographic references produced
y an entity (faculty, center, department, individual) are auto-
atically identiﬁed in the Medline database and analyzed. The
rimary objective was to make an inventory of the scientiﬁc pro-
uction within a facility in a quantitative and qualitative manner,





877-0568/© 2014 Elsevier Masson SAS. All rights reserved.analyzing collaborations and changes in production over time,
which can provide a better handle on a facility’s research activity
and its reach (up-and-coming teams, collaborations).
1. How SIGAPS works
The SIGAPS software searches the Medline database of biomed-
ical and life sciences journal citations via the PubMed server.
Researchers are identiﬁed by their last name and initial of their
ﬁrst name (and alias for complex names). The software uses this
information to download all of the publications associated with this
name. The ﬁrst validation step is automated: the software retains
publications in which the author’s address matches the facility’s
address, or indicates collaboration with other authors at the facil-
ity, or has a single name, which eliminates a certain number of
unwanted publications upfront. The next validation step is carried
out by each facility: every year, the system administrator reviews
the list of automatically preselected publications. The ﬁnal vali-
dation step is carried out by individual researchers through the
SIGAPS website. This ﬁnal review by the researcher ensures the
highest possible reliability. The author will contact the facility’s
administrator if there are errors or an article was missed during
the automatic selection step (article with uncommon collaboration,
errors or change in author’s name, etc.).In the second phase, the SIGAPS software calculates a score for
the facility, department or researcher. This score, which is updated
annually, is based on the number and quality of the publications
and the author’s ranking on each paper. Quality is based on the











































Aig. 1. Classiﬁcation of journals according to the Thomson Institute for Scientiﬁc Info
oncept of the “relative” impact factor within the specialty or ﬁeld.
n each ﬁeld (about 170 in all), the journals are ranked into ﬁve
lasses (A, B, C, D and E) according to their impact factor or listed
s non-classiﬁed (NC). This classiﬁcation is based on data from the
ournal Citation Reports (JCR) of the Thomson Institute for Scientiﬁc
nformation (ISI). The A to E ranks are determined as a function of
he impact factor percentiles (Fig. 1).
Each class is allocated a weighting coefﬁcient. In 2013, this was
 points for class A journals, 6 points for B journals, 4 points for C
ournals, 3 points for D journals, 2 points for E journals and 1 point
or NC journal. A second weighting coefﬁcient takes into account
he author’s ranking on a paper. In 2013, this was 4 points for ﬁrst
r last author, 3 points for second author, 2 points for third and
econd-to-last author and 1 point for another contributing author.
In 2008, the SIGAPS score was calculated by multiplying these
wo coefﬁcients, which results in each article being given a score
etween 1 and 32. For example, a publication in an A journal by the
rst author will be assigned a score of 32 (8 × 4) and a publication
n a NC journal by a ﬁfth author will be assigned a score of 1 (1 × 1).
 team’s or researcher’s score is the sum of the scores assigned to
ll their articles. If an article lists several authors from the same
eam, the score retained for the article corresponds to the score of
he highest ranked author. This ensures that a paper is only counted
nce per entity (department, center or facility). Conversely, when
wo people who publish together belong to two different centers
ithin a facility, this publication is counted once for each center,
ut only the best score is retained by the software for the facility
core. As a consequence, the sum of the individual or center scores
ill be higher than the sum of the facility score. Since the method
sed to calculate the SIGAPS score has changed over time, the scores
annot be compared from year-to-year, especially before and after
008.
For example, in the 2013 MERRI budget corresponding to the
012 export (2008–2011 period), an article in an A journal scoring
2 SIGAPS points (for ﬁrst or last author) corresponded to a grant of
bout D18,000, knowing that this same publication will be counted
or 4 years. This is the facility score. But this same funding formula
annot be applied to individual researchers. Problems related to
ttributing scores to a certain center or department within a facility
re hard to solve: a relative share has to be determined to distribute
he score over the entire department or the highest ranked person
or center) on the article must be retained for each article and score.
. Limitations of SIGAPSThe limitations of the SIGAPS scoring system revolve around
ts use of the impact factor (IF) for the score calculations [4–6].
 journal’s impact factor for a given year is the average numberon (ISI). Journals are classiﬁed from A to E according to the impact factor percentiles.
of citations for each published article in that journal by journals
indexed in the Thomson Reuters Science Citation Index (SCI) dur-
ing the two  previous years. For example, a journal will have an
impact factor of 3 in 2013 if its 2011 and 2012 articles are cited an
average of three times each in 2013 by all of the journals indexed
in the SCI. This is the standard IF with self-citations, provided by
Thomson Reuters in the Metrics File used for calculate the journal
classes.
The impact factor has been used for a long time to evaluate the
prestige of journals, but it is not without controversy. This clas-
siﬁcation system places non-English journals at a disadvantage.
However, the IF continues to be the journal ranking system that cor-
responds approximately to the accepted hierarchy of journals and
to the actual diffusion of research results. This is especially true in
the SIGAPS because the IF is evaluated by groups of specialties, not
overall (Table 1). In addition, the impact factor is an objective mea-
sure that is calculated in a transparent and known manner. Journals
have the ability to increase their impact factor, for example by pub-
lishing reviews about trendy topics. The IF within a specialty can
range from 0 to 153, as it does in Oncology (Electronic Appendix 1).
Orthopedics has a maximum impact factor of 4.439 and is ranked
127th out of 177 specialties. The Revue de Chirurgie Orthopédique
et de l’Appareil Locomoteur (RCO) journal was indexed in French
but had a low impact factor (maximum of 0.543) and was always
considered a group E journal. As of 2009, the Orthopaedics & Trau-
matology: Surgery & Research (OTSR) journal is the indexed English
version of RCO’s successor. The French journal Revue de Chirurgie
Orthopédique et Traumatologique is no longer indexed in Medline.
The impact factor of the old RCO in French never went above 0.54,
but the English version (OTSR) surpassed 1.0 in 2012 and reached
1.168 in 2013 (Fig. 2).
Other methods to evaluate journals have been discussed, such
as using the SCOPUS database to generate a SCImago ranking of
156 journals in the “Orthopedics and Sports Medicine” category
(http://www.scimagojr.com) (Electronic Appendix 2) (Fig. 3). OTSR
is ranked “Q2” on a 4-point scale, whereas it lies in the “D” class
in the current SIGAPS ISI classiﬁcation, which takes only 58 jour-
nals into consideration. Most of these journals are in English but
they are not entirely in the “Orthopedics and Sports Medicine” ﬁeld
(Table 1).
Use of other bibliometric indicators such as the H-index to
directly measure the impact of publications is being explored [7].
This index takes into account an author’s productivity (how many
papers an author publishes) and his or her impact (how many times
the papers are cited in other journals). An H-index of 10 means
that 10 of the researcher’s papers have been cited at least 10 times
each. Unfortunately, this index places younger researchers at a
disadvantage. It is cumulative (annuity effect) and does not take
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Table  1
ISI ranking used to calculate the SIGAPS score in the “Orthopedics and Sports Medicine” category.
ISSN Title 2008 2009 2010 2011 2012 Field(s)
IF  Class IF Class IF Class IF Class IF Class
0363–5465 Am J Sports Med  3.646 A 3.605 A 3.821 A 3.792 A 4.439 A TC XW
0749–8063 Arthroscopy 2.503 B 2.608 B 3.317 A 3.024 B 3.103 A TC YA
0021–9355 J Bone Joint Surg Am 3.313 A 3.427 A 2.967 B 3.272 A 3.234 A TC YA
0736–0266 J Orthop Res 2.963 A 3.112 A 2.976 A 2.811 B 2.875 A TC
0190–6011 J Orthop Sports Phys Ther 1.895 C 2.482 B 2.538 B 3 B 2.947 A TC WC  XW
1063–4584 Osteoarthr Cartil 4.082 B 3.888 A 3.953 B 3.904 B 4.262 A TC WH
0031–9023 Phys Ther 2.19 B 2.082 B 2.645 A 3.113 A 2.778 A TC WC
1745–3674 Acta Orthop 1.762 C 1.909 C 1.897 C 2.168 B 2.736 B TC
0009–921X Clin Orthop Relat Res 1.893 C 2.065 C 2.116 C 2.533 B 2.787 B TC YA
0341–2695 Int Orthop 1.235 D 1.825 C 1.561 C 2.025 C 2.319 B TC
1067–151X J Am Acad Orthop Surg 2.25 B 1.58 C 2.547 B 2.662 B 2.455 B TC YA
1836–9553 J Physiother NC NC NC 1.917 C 2.255 B TC WC
1058–2746 J  Shoulder Elbow Surg 1.827 C 1.934 C 2.311 B 2.747 B 2.319 B TC YA XW
0942–2056 Knee Surg Sports Traumatol
Arthrosc
1.696 C 1.674 C 1.857 C 2.209 B 2.676 B TC YA XW
1529–9430 Spine J 2.902 C 2.902 C 3.024 B 3.29 B 3.355 B TC RT
1471–2474 BMC Musculoskelet Disord 1.987 C 1.88 C 1.941 C 1.577 C 1.875 C TC WH
0268–0033 Clin Biomech (Bristol, Avon) 2 C 1.759 C 2.036 C 2.071 C 1.869 C TC IG XW
1050–642X Clin J Sport Med  1.595 D 1.5 D 2.11 C 2.119 C 1.6 C UM TC XW
0940–6719 Eur Spine J 2.396 C 1.956 C 1.994 C 1.965 D 2.133 C TC RT
1071–1007 Foot Ankle Int 1.061 D 1.101 D 1.092 D 1.218 D 1.474 C TC
0020–1383 Injury 1.946 C 2.383 B 2.269 C 1.975 C 1.931 C FF TC YA DS
0883–5403 J Arthroplasty 1.556 C 1.787 C 2.207 B 2.384 B 2.11 C TC
0363–5023 J Hand Surg Am 1.447 C 1.326 C 1.439 C 1.354 C 1.572 C TC YA
0890–5339 J Orthop Trauma 1.877 C 1.777 C 1.792 C 2.135 B 1.751 C TC XW
0968–0160 Knee 1.49 C 1.126 D 1.403 C 1.736 C 2.01 C TC YA XW
0091–3847 Phys Sportsmed NC NC 1.023 D 1.023 D 1.344 C ML  TC XW
0362–2436 Spine 2.793 C 2.624 C 2.51 C 2.078 C 2.159 C TC RT
0936–8051 Arch Orthop Trauma Surg 0.965 D 1.117 D 1.196 D 1.369 C 1.358 D TC YA
1413–3555 Braz J Phys Ther NC 0.338 E 0.368 E 0.444 E 1 D TC
0300–8207 Connect. Tissue Res 1.113 E 1.552 D 2.093 D 1.198 E 1.788 D DR TC
1083–7515 Foot Ankle Clin 0.709 D 0.709 D 0.709 D 0.709 D 0.899 D TC
0966–6362 Gait Posture 2.743 C 2.576 C 2.313 C 2.123 D 1.969 D RU TC XW
0749–0712 Hand Clin 0.681 D 0.687 D 0.802 D 0.717 D 0.946 D TC
8750–7315 J Am Podiatr Med  Assoc 0.586 E 0.598 D 0.523 D 0.567 D 0.768 D TC
1067–2516 J Foot Ankle Surg 0.76 D 0.76 D 0.76 D 0.516 E 0.86 D TC YA
1753–1934 J Hand Surg Eur Vol 0.7 E 0,044 E 0.87 D 1.171 D 1.223 D TC YA
0894–1130 J Hand Ther 0.933 D 0.612 E 1.164 D 1.556 C 1.169 D TC WC  YA
0949–2658 J Orthop Sci 0.94 D 1.027 D 0.839 D 0.843 D 0.96 D TC
1749–799X J Orthop Surg Res 1.013 D 1.013 D 1.013 D 1.013 D 1.013 D TC
0271–6798 J Pediatr Orthop 1.569 C 1.226 D 1.153 D 1.156 D 1.163 D TQ TC
1536–0652 J Spinal Disord Tech 1.365 D 1.206 D 1.333 D 1.503 D 1.767 D TC RT
0147–7447 Orthopedics 0.588 D 0.594 D 1.098 D 2.664 B 1.054 D TC
0744–6020 Orthop Nurs 0.548 E 0.573 E 0.304 E 0.471 E 0.688 D RZ TC
1877–0568 Orthop Traumatol Surg Res NC 0.52 E 0.52 E 0.943 D 1.061 D TC YA
0001–6462 Acta Orthop Belg 0.403 E 0.403 E 0.392 E 0.401 E 0.629 E TC
1017–995X Acta Orthop Traumatol Turc NC NC 0.309 E 0.337 E 0.597 E TC
1305–8282 Eklem Hastalik Cerrahisi NC 0.25 E 0.404 E 0.708 D 0.656 E TC YA
1633–8065 Eur J Orthop Surg Traumatol NC 0.105 E 0.146 E 0.097 E 0.181 E TC YA
1053–8127 J Back Musculoskelet Rehabil 0.196 E 0.172 E 0.292 E 0.587 E 0.613 E TC WC  XW
1060–152X J Pediatr Orthop B 0.742 E 0.66 E 0.421 E 0.467 E 0.532 E TQ TC
2000–656X J Plast Surg Hand Surg NC NC NC 0.017 E 0.078 E TC YA
0934–6694 Oper Orthop Traumatol NC NC 0.433 E 0.459 E 0.474 E TC
0085–4530 Orthopade 0.573 E 0.543 E 0.583 D 0.51 E 0.506 E TC
0309–3646 Prosthet Orthot Int 0.377 E 0.563 D 0.634 D 0.95 D 0.624 E TC WC
0932–0555 Sportverletz Sportschaden 0.325 E 0.415 E 0.521 E 0.612 D 0.458 E TC XW
1864–6697 Z Orthop Unfall 0.178 E 0.313 E 0.343 E 0.522 E 0.652 E TC












1120–7000 Hip Int 0.215 E 0.343 
0030–5898 Orthop Clin. North Am 1.431 D 1.245 
he author ranking into consideration. In addition, it considerably
avors popular specialties with high citation rates versus special-
ies with narrow readership, where the impact factor and number
f citations will never attain those of well-known internal medicine
ournals (NEJM, Lancet, JAMA) or those in immunology, genetics or
ncology.Another limitation of SIGAPS is the lack of correspondence
etween the ISI scientiﬁc ﬁelds and the sub-sections of the French
ational Council of Universities (CNU). If a journal is multidis-
iplinary, the SIGAPS category is calculated as a function of the0.792 D 0.763 D NC TC
1.398 C 1.398 C NC TC
various ﬁelds in which the journal is allocated to. This calculation
can have an impact on the ﬁnal category, which may  not realistically
reﬂect on how prestigious a journal is in the eyes of the scientists
in that ﬁeld. The “old” RCO was considered the top journal in the
French orthopedics community, but had a low impact factor.
If the goal was  only to accumulate points, it would be more effec-
tive for an author to send a short-format paper (case report) to a
French journal that is easy to access and indexed in Medline, but
this would be contrary to the research excellence objective [8,9].
This is the main reason that a cumulative score was replaced in
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iFig. 3. Relationship between the impact factor (IF) and the SCImago Jo
008 by a multiplicative score, which encourages researchers to
ublish in journals with a high impact factor in their specialty area,
nstead of French journals with a narrow readership. A recent study
as shown an inverse correlation between the SIGAPS score and the
roportion of articles published in French at the Rouen university
ospital [10]. This will get worse because fewer and fewer French
edical research journals are indexed in Medline. The “old” Revue
e Chirurgie Orthopédique journal is no longer indexed in Medline
ecause it no longer exists. It was replaced by the OTSR, which
ublished articles online in English and by the Revue de Chirurgie
rthopédique et Traumatologique (RCOT),  which is not indexed in
edline but is still listed in SCOPUS (Electronic Appendix 2). All
he articles published in the latter journal are in French, including
rench translations of the OTSR articles.
Multicenter publications are, in the end, more expensive for the
ollectivity because each facility is funded based on the best rank
f its authors, which brings an author’s relative position on a paper
nto play. This calculation method could be a barrier to interfacility
ollaborations and even intercenter collaboration within a facility
ecause SIGAPS is a ﬁnancial distribution tool used for an overall
udget that is set annually. Because of how SIGAPS is currently
sed in France, attributing value to publications is only effective
or health facilities that have access to the variable MERRI ﬁnancing
more than 150 facilities in 2013). This ﬁnancing is dependent on a
inimal output threshold of D200,000 in 2012, reviewed annually.
his threshold concept, stemming from a French policy and desire
ot to spread research funding too thinly, is still under discussion.
Despite these limitations, SIGAPS is an original, reproducible
ool developed to estimate the quantity and quality of Medline-
ndexed publications produced in France [11]. It has multiple Rank (SJR) for the ﬁrst 95 journals listed in the SCOPUS classiﬁcation.
applications, beyond distributing MERRI funds. It is also used for
overall evaluation of hospitals or specialties. It has been adopted by
most of the sub-sections of the French National Council of Universi-
ties to evaluate candidates for tenure at universities (full University
Professor). But this use has been controversial since it is not what
SIGAPS was created for [12–15]. The application period must be
well deﬁned: a SIGAPS score cannot be interpreted unless the
period over which it was  calculated is speciﬁed. The software calcu-
lates the score over a 10 year period; the Ministry of Health (DGOS)
uses the last four years and the evaluations are done with the last
ﬁve years. For researchers, the score’s variation over time, instead
of the cumulative or absolute score, will likely provide the best view
of past research activity, once the SIGAPS calculation method has
stabilized.
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Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.otsr.2014.06.020.References
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